Cambrex to Invest 16.5 Million USD in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
By asianet
Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s … Continued